Trademark Overview
On Monday, June 9, 2025, a trademark application was filed for ANIVANCE AI with the United States Patent and Trademark Office. The USPTO has given the ANIVANCE AI trademark a serial number of 99224937. The federal status of this trademark filing is PUBLISHED FOR OPPOSITION as of Tuesday, January 6, 2026. This trademark is owned by Anivance AI Corporation. The ANIVANCE AI trademark is filed in the Computer & Software Products & Electrical & Scientific Products, Medical Instrument Products, Computer & Software Services & Scientific Services, and Medical & Beauty Services & Agricultural Services categories with the following description:
Organ-on-a-chip for laboratory and research purposes; Biotechnology instruments in the nature of microscopes; Microfluidic systems comprised of electric microfluidic sensors and microfluidic chips; Cell culture devices for laboratory use, namely, cell culture dishes, and tissue culture flasks; Scientific laboratory research instruments for DNA analysis; Biological simulation devices in the nature of medical training simulators; Diagnostic microfluidic devices in the nature of diagnostic apparatus for research laboratory use for detecting pathogens, DNA analysis, and thermal imaging; In vitro diagnostic devices in the nature of diagnostic apparatus for research laboratory use for detecting pathogens, and DNA analysis
Research and development services in the field of biotechnology; Organ-on-a-chip development and design; Laboratory services for the production of pharmaceuticals in the nature of testing of in vitro pharmaceuticals; Technical consultation and support services in the field of biosequestration of carbon dioxide; Laboratory services for the production of pharmaceuticals in the nature of testing of in vitro pharmaceuticals in the field of cellular biology; Laboratory services for the production of pharmaceuticals in the nature of providing simulations of cells in the field of cellular biology; Quality management services, namely, quality evaluation and analysis, quality assurance, and quality control, in the field of human tissue for cellular biology purposes; Research and development in the field of cellular biology; Development of biological simulation systems; Development of microfluidic technology; Diagnostic services for organ-on-a-chip systems; Medical research services in the field...
Medical diagnostic services; Personalized medical services in the nature of emergency medical services; Health assessment services and managed health care services; Medical evaluation of cell therapy
Artificial organ-on-a-chip for medical use; Diagnostic microfluidic devices in the nature of medical diagnostic apparatus for testing blood sugar levels, cancer cells, and DNA; In vitro diagnostic devices in the nature of medical diagnostic apparatus for testing blood sugar levels, cancer cells, and DNA; Cell therapy devices in the nature of medical devices being tubing and valve assembly set and electromechanical fluidic instrument, and other similar or related devices, which process human red blood cells with clinical medical reagents for the purpose of converting blood groups for use in blood transfusions; Medical testing chips being lab-on-a-chip in the nature of medical diagnostic apparatus for testing blood sugar levels, cancer cells, and DNA; Medical biological simulation devices in the nature of medical diagnostic apparatus for detecting disease progression and also incorporating recorded software for simulating organ functions and drug interactions; Medical instruments, namely...
